New Imaging-Guided combo therapy aims to slow prostate cancer spread
NCT ID NCT06832774
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding targeted local treatments (like radiation or surgery) to standard hormone therapy can slow disease progression in men with metastatic hormone-sensitive prostate cancer. Doctors will use PSMA PET/CT scans to find remaining active tumors after initial hormone therapy. The trial enrolls 192 men who have not had prior prostate cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gonadotropin releasing hormone analog (GnRHa) plus novel hormone therapy (abiraterone, apalutamide, or rezvilutamide) combined with local treatment (radiotherapy, surgery, or HIFU)
- What this could lead to
- If successful, this approach could help doctors personalize treatment for metastatic prostate cancer, potentially delaying disease progression and extending survival.
- What could go wrong
- This is a phase 2 trial with only 192 participants, so results may not apply to all patients. The added local treatments carry risks like radiation side effects or surgical complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, 200080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glow-in-the-dark dye may help surgeons spot hidden prostate cancer cells
- Radiation zaps prostate cancer spots in men not helped enough by hormone drugs
- Could a special PET scan spot returning prostate cancer sooner?
- Lab-Grown Mini-Tumors could predict best prostate cancer therapy
- Could a common ED drug shield prostate cancer patients from chemo nerve pain?
- Can we safely zap more cancer spots? new study pushes radiation limits